The Effect of Pharmacist Intervention on Blood Pressure Control

NCT ID: NCT01233193

Last Updated: 2016-05-06

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 140 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2010-02-28
• Study Completion Date: 2011-09-30

Brief Summary

The purpose of the study is to test if a Pharmacist Intervention Program with home blood pressure monitoring (HBPM) improves or controls pharmacological adherence and blood pressure levels in hypertensive patients under pharmacological treatment, compared to those who receive usual care in a community pharmacy setting.

Detailed Description

Hypertension is a major health concern worldwide due to its deleterious impact on the population in terms of excessive morbidity and mortality, especially when there is insufficient hypertension control and prevention at the community level.

Conditions

Hypertension

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: NONE

Study Groups

Intervention

The intervention group receive an pharmacist intervention (health education, Home Blood Pressure Monitoring and Referral to physician as needed) This group will be followed for 6 months

Group Type: EXPERIMENTAL

Health education, Home blood pressure monitoring

Intervention Type: BEHAVIORAL

Health education (on hypertension, smoking, healthy diet, obesity, physical inactivity and adherence to antihypertensive medications and home blood pressure monitoring) . The patient will be referred to physician when needed. The patient will be followed up during 6 months.

Control

The control group receive usual care in the community pharmacy

Group Type: NO_INTERVENTION

No interventions assigned to this group

Interventions

Health education, Home blood pressure monitoring

Health education (on hypertension, smoking, healthy diet, obesity, physical inactivity and adherence to antihypertensive medications and home blood pressure monitoring) . The patient will be referred to physician when needed. The patient will be followed up during 6 months.

Intervention Type: BEHAVIORAL

Other Intervention Names

pharmaceutical health education

Eligibility Criteria

Inclusion Criteria

• Patients of both genders between the ages of 18 and 80 years, who access the pharmacy to fill their own prescription for hypertension.

Exclusion Criteria

• Patient living with an other Hypertensive patient treated with the same medications
• Pregnant women
• Hypertensive patients with levels of systolic/diastolic blood pressure ≥ 180mmHg/110mmHg
• Patient with secondary hypertension, kidney or liver failure
• Patients already included in a care program for hypertensive patients
• Patients with a new treatment for hypertension (less than 1 month)

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Universidad de Granada

OTHER

Sponsor Role: lead

Responsible Party

Pharmaceutical Care Research Group of the University of Granada

Principal Investigators

Maria Jose Faus, PhD

Role: STUDY_DIRECTOR

Universidad de Granada

Locations

Community Pharmacies

Granada, Andalusia, Spain

Community Pharmacies

Jaén, Andalusia, Spain

Countries

Spain

Other Identifiers

DMM01-FAR-10

Identifier Type: -

Identifier Source: org_study_id